Foresite Capital Fund VI LP

13D and 13G Filings

13D/G filings: 13D on 3 securities, 13G on 5 securities
Location: Larkspur, CA
CIK: 0001932516
Form D filings: 2 filings
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 3 securities · may seek to influence control
Latigo Biotherapeutics, Inc. 13D LTGO · 517954103	LTGO	517954103	14.5%	9,181,328	13D	8/17/2026 Event 8/10/2026
Foresite Capital Fund VI LP			3.5%	2,203,800
Foresite Capital Management VI, LLC			3.5%	2,203,800
Foresite Capital Fund V, L.P.			5.6%	3,562,984
Foresite Capital Management V, LLC			5.6%	3,562,984
Foresite Capital Opportunity Fund V, L.P.			5.4%	3,414,544
Foresite Capital Opportunity Management V, LLC			5.4%	3,414,544
James B. Tananbaum			14.5%	9,181,328
Latigo Biotherapeutics, Inc. 13D LTGO · 517954103	LTGO	517954103	14.5%	9,181,328	13D	8/17/2026 Event 8/10/2026
Foresite Capital Fund VI LP			3.5%	2,203,800
Foresite Capital Management VI, LLC			3.5%	2,203,800
Foresite Capital Fund V, L.P.			5.6%	3,562,984
Foresite Capital Management V, LLC			5.6%	3,562,984
Foresite Capital Opportunity Fund V, L.P.			5.4%	3,414,544
Foresite Capital Opportunity Management V, LLC			5.4%	3,414,544
James B. Tananbaum			14.5%	9,181,328
Alumis Inc. 13D/A ALMS · 022307102	ALMS	022307102	12.7%	15,693,820	13D/A	4/3/2026 Event 4/1/2026
Foresite Capital Fund VI LP			3.4%	4,247,670
Foresite Capital Management VI, LLC			3.4%	4,247,670
Foresite Capital Fund V, L.P.			4.6%	5,702,536
Labs Co-Invest V, LLC			0.2%	194,459
Foresite Capital Management V, LLC			4.8%	5,896,995
Foresite Capital Opportunity Fund V, L.P.			2.4%	2,908,332
Foresite Capital Opportunity Management V, LLC			2.4%	2,908,332
Foresite Labs Fund I, L.P.			1.6%	1,960,337
Foresite Labs Management I, LLC			1.6%	1,960,337
Foresite Labs Affiliates 2021, LLC			0%	0
Foresite Labs, LLC			0%	0
James B. Tananbaum			12.7%	15,693,820
Schedule 13G · 5 securities · passive
IRulya Therapeutics Inc. 13G IRLA · 22053A305	IRLA	22053A305	6.0%	652,039	13G	10/14/2026 Event 10/6/2026
Foresite Capital Fund VI LP			4.5%	489,029
Foresite Capital Management VI, LLC			4.5%	489,029
Foresite Public & Crossover Opportunities Fund I, L.P.			1.5%	163,010
Foresite Public & Crossover Opportunities Management I, LLC			1.5%	163,010
James B. Tananbaum			6.0%	652,039
Verastem, Inc. 13G/A VSTM · 92337C203	VSTM	92337C203	3.6%	3,146,631	13G/A	5/15/2026 Event 3/31/2026
Foresite Capital Fund VI LP			3.6%	3,146,631
Foresite Capital Management VI LLC			3.6%	3,146,631
Tananbaum James B.			3.6%	3,146,631
CASI Pharmaceuticals, Inc. 13G/A CASIF · G1933S101	CASIF	G1933S101	0%	0	13G/A	2/13/2026 Event 12/31/2025
Foresite Capital Fund VI LP			0%	0
Foresite Capital Management VI LLC			0%	0
James Tananbaum			0%	0
enGene Holdings, Inc. 13G/A ENGN · 29286M105	ENGN	29286M105	0%	0	13G/A	2/14/2025 Event 9/30/2024
Foresite Capital Fund VI, L.P.			0%	0
Foresite Capital Management VI, LLC			0%	0
James Tananbaum			0%	0
RAPT Therapeutics, Inc. 13G RAPT · 75382E109	RAPT	75382E109	9.3%	12,500,000	13G	12/30/2024 Event 12/23/2024
Foresite Capital Fund VI, L.P.			9.3%	12,500,000
Foresite Capital Management VI, LLC			9.3%	12,500,000
James Tananbaum			9.3%	12,500,000

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.